Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.64596 | 27 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.58143 | 25 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.58675 | 25 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.53866 | 25 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.53246 | 25 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.64394 | 25 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.5925 | 24 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.56366 | 25 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.55854 | 25 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.57611 | 25 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.56967 | 25 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.56087 | 25 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.57789 | 25 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.57074 | 25 |